Brief: Zealand Pharma Q1 Operating Result DKK -539 Million
07/05/2026 06:00
May 07 (Reuters) - Zealand Pharma Q1 revenue DKK 34 million. Q1 operating expenses DKK -573 million
Recent news on Zealand Pharma A/S
See all newsRCS - Accession Theraptcs. - Accession Therapeutics: Board appointments
Brief: Zealand Pharma Announces Positive Topline Results From Phase 1 Trial With ZP9830
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Brief: Zealand Pharma, Generate Biomedicines Enter Collaboration, License Agreement
Zealand Pharma, Generate strike AI obesity drug deal worth up to $1.2 billion (updated)